Anika Therapeutics (ANIK) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Anika Therapeutics (ANIK) over the last 15 years, with Q3 2025 value amounting to 0.6.
- Anika Therapeutics' Asset Utilization Ratio rose 7103.68% to 0.6 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.6, marking a year-over-year increase of 7103.68%. This contributed to the annual value of 0.51 for FY2024, which is 2996.53% up from last year.
- As of Q3 2025, Anika Therapeutics' Asset Utilization Ratio stood at 0.6, which was up 7103.68% from 0.61 recorded in Q2 2025.
- Anika Therapeutics' 5-year Asset Utilization Ratio high stood at 0.61 for Q2 2025, and its period low was 0.33 during Q4 2022.
- In the last 5 years, Anika Therapeutics' Asset Utilization Ratio had a median value of 0.4 in 2021 and averaged 0.43.
- Per our database at Business Quant, Anika Therapeutics' Asset Utilization Ratio crashed by 2321.93% in 2023 and then surged by 7103.68% in 2025.
- Anika Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.42 in 2021, then dropped by 22.59% to 0.33 in 2022, then increased by 23.5% to 0.4 in 2023, then surged by 36.91% to 0.55 in 2024, then increased by 8.3% to 0.6 in 2025.
- Its Asset Utilization Ratio stands at 0.6 for Q3 2025, versus 0.61 for Q2 2025 and 0.6 for Q1 2025.